NDC properties for "temazepam 7.5 MG Oral Capsule" (RxCUI 198243)
About this data
The tables show NDC propoerties for temazepam 7.5 MG Oral Capsule with the RxCUI 198243
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for temazepam 7.5 MG Oral Capsule (RxCUI 198243)
ANDA | ANDA070920 |
---|---|
ANDA | ANDA071457 |
ANDA | ANDA078581 |
ANDA | ANDA201781 |
ANDA | ANDA203482 |
ANDA | ANDA211542 |
MMSL_CODE | BD3274 |
MMSL_CODE | CD3274 |
NDA | NDA018163 |
RxCUI | 198243 |
SNOMEDCT | 371376001 |
SPL_SET_ID | 147a51d7-2f8d-43e8-b0ed-a79a2cdfc0a9 |
SPL_SET_ID | 23ff2d2f-4770-4760-9b41-a850329bb2c7 |
SPL_SET_ID | 2c4f564d-d349-4f9b-b3f4-f3f0d9706a4d |
SPL_SET_ID | 3ce42f0e-821e-4c9a-8f6b-60621628fd4b |
SPL_SET_ID | 405b1ee2-777b-4fd3-b4ee-bd2aacbe1dc1 |
SPL_SET_ID | 4ac590e9-af71-43c0-a836-b700115d7ba2 |
SPL_SET_ID | 6559dfee-c29b-4707-8b30-8ca14bf23ea0 |
SPL_SET_ID | 85327378-86a3-4448-9185-e20bb20ebf45 |
SPL_SET_ID | 8f54731f-c5b7-492c-acb0-444c5fbb7029 |
SPL_SET_ID | 93b1be7f-ec41-46bb-a258-56cb459e2c92 |
SPL_SET_ID | a3f06243-fa03-4cbd-951a-144ec43dcdfd |
SPL_SET_ID | aeaa1606-a75f-44ad-99de-56567fcc40dc |
SPL_SET_ID | be68c6e0-17ad-40fe-9bc1-58abe24b53f6 |
SPL_SET_ID | c9bc61b4-a579-4003-98da-b6f6e381c150 |
SPL_SET_ID | d4a241c7-a4de-4f6b-b831-e063cf8c3d54 |
SPL_SET_ID | db839409-8e95-41d3-804e-dcd5d11f4934 |
VUID | 4002700 |
Prescribable Synonym | temazepam 7.5 MG Oral Capsule |
RXNAV_STR | temazepam 7.5 MG Oral Capsule |
RxNorm Name | temazepam 7.5 MG Oral Capsule |
Related queries | Interactions (for RxCUI 198243) |
NDC Properties
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |
NDC Item 00378311001
NDC 9 | 0378-3110 |
---|---|
NDC 10 | 0378-3110-01 |
NDC Item | 00378311001 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3110-01) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 411913 |
Imprint code | MYLAN;3110 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-05-18 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-3110 |
NDC Item 00406996001
NDC 9 | 0406-9960 |
---|---|
NDC 10 | 0406-9960-01 |
NDC Item | 00406996001 |
Packaging | 100 CAPSULE in 1 BOTTLE (0406-9960-01) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 786605 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | SpecGx LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 0406-9960 |
NDC Item 00904643604
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-04 |
NDC Item | 00904643604 |
Packaging | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 00904643660
NDC 9 | 0904-6436 |
---|---|
NDC 10 | 0904-6436-60 |
NDC Item | 00904643660 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0904-6436-60) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 865031 |
Imprint code | 7;5mg;Novel120 |
Labeler | Major Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0904-6436 |
NDC Item 43353015230
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-30 |
NDC Item | 43353015230 |
Packaging | 30 CAPSULE in 1 BOTTLE (43353-152-30) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015253
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-53 |
NDC Item | 43353015253 |
Packaging | 60 CAPSULE in 1 BOTTLE (43353-152-53) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353015260
NDC 9 | 43353-152 |
---|---|
NDC 10 | 43353-152-60 |
NDC Item | 43353015260 |
Packaging | 90 CAPSULE in 1 BOTTLE (43353-152-60) |
ANDA | ANDA071457 |
COLORTEXT | WHITE(opaque body),PINK(opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 274934 |
Imprint code | 7;5;mg;Novel;120 |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-03-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 43353-152 |
NDC Item 43353071130
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-30 |
NDC Item | 43353071130 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-30) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071153
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-53 |
NDC Item | 43353071153 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-53) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43353071160
NDC 9 | 43353-711 |
---|---|
NDC 10 | 43353-711-60 |
NDC Item | 43353071160 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-711-60) |
ANDA | ANDA070920 |
COLORTEXT | ORANGE(peach opaque),WHITE(ivory opaque) |
Color | C48331;C48325 __ |
DCSA | CIV |
FDA SPL set id | 123301 |
Imprint code | MYLAN;3110 |
Labeler | Aphena Pharma Solutions - Tennessee, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-10-25 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43353-711 |
NDC Item 43547061110
NDC 9 | 43547-611 |
---|---|
NDC 10 | 43547-611-10 |
NDC Item | 43547061110 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) |
ANDA | ANDA201781 |
COLORTEXT | BLUE(blue opaque/pink opaque) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 812831 |
Imprint code | 7;5mg;S611 |
Labeler | Solco Healthcare U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-01-05 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 43547-611 |
NDC Item 46708037930
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-30 |
NDC Item | 46708037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (46708-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 46708037931
NDC 9 | 46708-379 |
---|---|
NDC 10 | 46708-379-31 |
NDC Item | 46708037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (46708-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 690537 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 46708-379 |
NDC Item 53489064801
NDC 9 | 53489-648 |
---|---|
NDC 10 | 53489-648-01 |
NDC Item | 53489064801 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (53489-648-01) |
ANDA | ANDA078581 |
COLORTEXT | white(opaque),turquoise(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 399603 |
Imprint code | Mutual;866 |
Labeler | Sun Pharmaceutical Industries Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 53489-648 |
NDC Item 62332037930
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-30 |
NDC Item | 62332037930 |
Packaging | 30 CAPSULE in 1 BOTTLE (62332-379-30) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 62332037931
NDC 9 | 62332-379 |
---|---|
NDC 10 | 62332-379-31 |
NDC Item | 62332037931 |
Packaging | 100 CAPSULE in 1 BOTTLE (62332-379-31) |
ANDA | ANDA211542 |
COLORTEXT | BLUE(opaque blue cap opaque pink body) |
Color | C48333 __ |
DCSA | CIV |
FDA SPL set id | 707869 |
Imprint code | A222 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-11-27 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 62332-379 |
NDC Item 63187071815
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-15 |
NDC Item | 63187071815 |
Packaging | 15 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-15) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071820
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-20 |
NDC Item | 63187071820 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-20) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071830
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-30 |
NDC Item | 63187071830 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-30) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071860
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-60 |
NDC Item | 63187071860 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-60) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63187071890
NDC 9 | 63187-718 |
---|---|
NDC 10 | 63187-718-90 |
NDC Item | 63187071890 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (63187-718-90) |
ANDA | ANDA078581 |
COLORTEXT | WHITE(opaque),TURQUOISE(opaque) |
Color | C48325;C48334 __ |
DCSA | CIV |
FDA SPL set id | 425784 |
Imprint code | Mutual;866 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-09-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63187-718 |
NDC Item 63629860101
NDC 9 | 63629-8601 |
---|---|
NDC 10 | 63629-8601-1 |
NDC Item | 63629860101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63629-8601-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 801649 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63629-8601 |
NDC Item 63739000333
NDC 9 | 63739-003 |
---|---|
NDC 10 | 63739-003-33 |
NDC Item | 63739000333 |
Packaging | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-003-33) / 10 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA071457 |
COLORTEXT | white(white opaque body),pink(pink opaque cap) |
Color | C48325;C48328 __ |
DCSA | CIV |
FDA SPL set id | 853339 |
Imprint code | 7;5mg;Novel120 |
Labeler | McKesson Corporation dba SKY Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 63739-003 |
NDC Item 65162058303
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-03 |
NDC Item | 65162058303 |
Packaging | 30 CAPSULE in 1 BOTTLE (65162-583-03) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058310
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-10 |
NDC Item | 65162058310 |
Packaging | 100 CAPSULE in 1 BOTTLE (65162-583-10) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058311
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-11 |
NDC Item | 65162058311 |
Packaging | 1000 CAPSULE in 1 BOTTLE (65162-583-11) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 65162058350
NDC 9 | 65162-583 |
---|---|
NDC 10 | 65162-583-50 |
NDC Item | 65162058350 |
Packaging | 500 CAPSULE in 1 BOTTLE (65162-583-50) |
ANDA | ANDA203482 |
COLORTEXT | white(OPAQUE BODY),blue(OPAQUE CAP) |
Color | C48325;C48333 __ |
DCSA | CIV |
FDA SPL set id | 824881 |
Imprint code | AMNEAL;583 |
Labeler | Amneal Pharmaceuticals LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2016-05-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 65162-583 |
NDC Item 67877014801
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-01 |
NDC Item | 67877014801 |
Packaging | 100 CAPSULE in 1 BOTTLE (67877-148-01) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014805
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-05 |
NDC Item | 67877014805 |
Packaging | 500 CAPSULE in 1 BOTTLE (67877-148-05) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 67877014830
NDC 9 | 67877-148 |
---|---|
NDC 10 | 67877-148-30 |
NDC Item | 67877014830 |
Packaging | 30 CAPSULE in 1 BOTTLE (67877-148-30) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 757749 |
Imprint code | 7;5mg;Novel120 |
Labeler | Ascend Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67877-148 |
NDC Item 68084054911
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-11 |
NDC Item | 68084054911 |
Packaging | 1 in 1 BLISTER PACK |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 68084054921
NDC 9 | 68084-549 |
---|---|
NDC 10 | 68084-549-21 |
NDC Item | 68084054921 |
Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11) |
COLORTEXT | pink,blue |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 767934 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | American Health Packaging |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2012-08-01 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 68084-549 |
NDC Item 71610000430
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-30 |
NDC Item | 71610000430 |
Packaging | 30 CAPSULE in 1 BOTTLE (71610-004-30) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000453
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-53 |
NDC Item | 71610000453 |
Packaging | 60 CAPSULE in 1 BOTTLE (71610-004-53) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 71610000460
NDC 9 | 71610-004 |
---|---|
NDC 10 | 71610-004-60 |
NDC Item | 71610000460 |
Packaging | 90 CAPSULE in 1 BOTTLE (71610-004-60) |
COLORTEXT | PINK,BLUE |
Color | C48328;C48333 __ |
DCSA | CIV |
FDA SPL set id | 382465 |
Imprint code | FOR;SLEEP;M;7;5;mg |
Labeler | Aphena Pharma Solutions - Tennessee, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2010-02-23 |
Marketing status | ACTIVE |
NDA | NDA018163 |
Score | 1 |
Shape | C48336 |
Size | 16 mm |
Related queries | Properties for NDC 9 71610-004 |
NDC Item 72162182601
NDC 9 | 72162-1826 |
---|---|
NDC 10 | 72162-1826-1 |
NDC Item | 72162182601 |
Packaging | 100 CAPSULE in 1 BOTTLE (72162-1826-1) |
ANDA | ANDA071457 |
COLORTEXT | PINK(pink opaque cap),WHITE(white opaque body) |
Color | C48328;C48325 __ |
DCSA | CIV |
FDA SPL set id | 774325 |
Imprint code | 7;5mg;Novel120 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-06-28 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 72162-1826 |